SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-17-005313
Filing Date
2017-11-07
Accepted
2017-11-06 17:53:51
Documents
66
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT txmd-10q_093017.htm 10-Q 885019
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 18376
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 14525
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 6736
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 6874
  Complete submission text file 0001387131-17-005313.txt   3916938

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT txmd-20170930.xml EX-101.INS 663345
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20170930.xsd EX-101.SCH 36854
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT txmd-20170930_cal.xml EX-101.CAL 56009
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT txmd-20170930_def.xml EX-101.DEF 160352
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20170930_lab.xml EX-101.LAB 297405
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20170930_pre.xml EX-101.PRE 239946
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 171180512
SIC: 2834 Pharmaceutical Preparations